The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $2.79, a high ...

LIfT BioSciences, ('LIfT' or 'the Company'), a rapidly emerging biotech and world leader in neutrophil immuno-therapies, today announces the appointment of Mark A. Exley, PhD as Chief Scientific ...

Bioprocessing has always been a bit late in adopting the latest engineering techniques, e.g. computational fluid dynamics to bioreactor design ...

The latest figures released by the Israel Innovation Authority (IIA) show a grim picture for 2024. Since the Gaza War started ...

Vertex Pharmaceuticals today announced that the European Commission has granted regulatory approval for a label expansion of KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in a combination regimen with ...

Tariffs will already impact FTSE 100 constituent Convatec (CTC), which generates 40 per cent of its sales in the US. Most of ...